- Joined
- Jul 29, 2004
- Messages
- 605
- Reaction score
- 135
- Points
- 4,711
Position posted last month on Pathologyoutlines at a mid-level academic in the midwest with starting pay at 130k with 11 applicants (most with a couple fellowships), now filled.
This is the future.
Position posted last month on Pathologyoutlines at a mid-level academic in the midwest with starting pay at 130k with 11 applicants (most with a couple fellowships), now filled.
This is the future.
...N of 1.
In the past 2 years I've seen academic salaries (mostly good places; AP jobs at assistant prof) range from $170K-$250. Most private or industry jobs I've seen are over $250 starting. In academia, despite reimbursement problems, the rates are going up, but so is the on-service component of the job. There are also relatively fewer positions increasing the volume/attending.
Anything less than 300k for a specialty full-time is not ideal, especially when as a student you have the choice of doing anything else (unless you suck).
Good medical students will pick better options than that, always. Get dizzy from a scope and cut up corpses for 170k, or work from home for three times looking at a screen? Or run your own office for two times as much working 3 day weeks, with patients that actually want to get better (plus you could do the most lucrative part of path on the side here too while leaving out all of the other crap)?
Like science? Why slum it out in path after that PhD when you can learn how to treat patients with cancer using modern technology, with far more money, respect and fulfillment?
Path and primary care are stuck with the incompetents and really bad IMGs. Even the mommy-trackers do derm gas or rads.
Shouldn't all residency graduates be "qualified"? If the rhetoric is that there are "good jobs for qualified applicants" then some residency programs either suck, or their recruits suck - probably both. Why have them there at all?
Your field is nuts. Plain and simple. I don't get it. I can't see how a field's leadership can be proud of the field when half of the people in it are below average.
The quality, not quantity, of your manpower is what is important. I've seen far too many people be harmed by terrible IMGs and weak CMGs to think any differently. Your field has to shape up.
what's your field bro?
I can't see how a field's leadership can be proud of the field when half of the people in it are below average.
The quality, not quantity, of your manpower is what is important. I've seen far too many people be harmed by terrible IMGs and weak CMGs to think any differently. Your field has to shape up.
Thanks for the advise. I still don't get what possible interest you have wasting your time on a path forum if you're not doing path, much less medicine in the US.
Btw, show me a field in which more that half of the people are above average. (Hint: it's called the average for a reason 😛)
ROAD
Rad onc
Trolling.
what's your field bro? you're not in path either, are you?
what's your field bro?
Rad onc has the same issues with the IOAS exception. Many urologists own their own radiation oncologists.
ROAD
Rad onc
This ain't Lake Wobegon. Half of the people in each of those fields are below average.
.......all domestic residents going abroad are by definition below average).
This is purely idiotic. ALL domestic residents who went to med school abroad are "by definition" below average? What are you talking about? Not all medical schools "abroad" are located in the Caribbean. .
Any comment on the new paper from Arch Pathol Lab Med?
"The Incredible Shrinking Billing Codes"
http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2014-0041-ED
I think the main problem lies in the lack of awareness by the general public of what pathologists do. When patients finally understand that their entire oncologic management and outcome depends on the pathologist's assessment (diagnosis, prognosis and prediction), maybe there will be stronger lobbying for stricter quality assurance in surgical pathology, and increased funding.
What is the point to save a few dollars on accurate diagnostic if it compromises the direction of thousand of dollars of chemo + rad onc treatment?
Food for thought.
Path and primary care are stuck with the incompetents and really bad IMGs. Even the mommy-trackers do derm gas or rads.
Depends on your vantage point. Mine is comparing the entry-level resident/medical student to their peers, not comparing residents within a discipline.
Derm residents are by and large top-notch clinically and academically (domestic trained high scorers, or exceptionally strong FMGs from world-class schools). By contrast, path residents and primary care residents are mostly below average (most FMGs and all domestic residents going abroad to proprietary for-profit medical schools are by definition below average).
As an FMG, I take offense to your statements above. I'm not a US citizen and went to a foreign medical school. I had top-notch USMLE scores (276/99, 279/99) and US clinical experience. I knew I would have been competitive applying to many other specialties, but I chose Pathology because I pursued what I loved. I'm in my last year of residency now, and could not have been happier with that decision, despite my realistic appraisal of the current job market.
Coincidentally, I got my resident in service exam score back today, and I obtained the highest overall score on the exam amongst all pathology residents in the country (694/>99). Please think before you stereotype all IMG/FMGs and regarding us, as a whole, as inferior species.
Path and primary care are stuck with the incompetents and really bad IMGs. Even the mommy-trackers do derm gas or rads.
I wouldn't diss primary care. Aside from supply and demand, there's another economic truism in life:
Whoever sees the money first or is the one shaking the hand in each major business transaction, makes the most money.
In medicine, that would mean the PCPs, first line specialists like derm and the surgeons. In the business world, they would be known as the "front office" or the revenue generators. Of course the insurance and management guys see the money even earlier.
Fee for service ironically is what has kept the cost-side "back office" medical specialties such as anesthesia, radiology, rad onc and path in the running for so long. The eventual retirement of fee for service in favor of ACOs is going to crush these specialties, because the money pool is going to first go through the PCPs and surgeons (they bring in the patients). The administrators will always in time kiss ass to the real revenue generators. With fee for service, it didn't matter as long as your code paid a defined amount, but if you get rid of fee for service, watch out because the truism will come back to play.
There are so many checks and balances in place to prevent that doomsday-type scenario from happening. For starters the surgical services wouldn't exactly thrive without competent anesthesiologists or pathologists. A few lawsuits, a few botched anesthetics or missed diagnoses or incorrectly called frozen sections with recurrences, etc... If you're right and money reigns supreme then imagine the money which would go into defending all these suits or paying out damages. Imagine all the frustrated surgeons leaving for greener pastures due to the incompetence of their colleagues with the resultant loss of income. Then the resultant rise in salaries, invisible hand-style, to attract better people.
Unless you're positing some kind of mass conspiracy wherein every single hospital in the nation simultaneously sets physician reimbursement to exactly the same level, it ain't gonna happen.
At least in pathology there is no temptation to replace MDs with midlevels.
I actually think the next big market correction will be (is) radiology reimbursement.
There are so many checks and balances in place to prevent that doomsday-type scenario from happening. For starters the surgical services wouldn't exactly thrive without competent anesthesiologists or pathologists. A few lawsuits, a few botched anesthetics or missed diagnoses or incorrectly called frozen sections with recurrences, etc... If you're right and money reigns supreme then imagine the money which would go into defending all these suits or paying out damages. Imagine all the frustrated surgeons leaving for greener pastures due to the incompetence of their colleagues with the resultant loss of income. Then the resultant rise in salaries, invisible hand-style, to attract better people.
Unless you're positing some kind of mass conspiracy wherein every single hospital in the nation simultaneously sets physician reimbursement to exactly the same level, it ain't gonna happen.
At least in pathology there is no temptation to replace MDs with midlevels.
I actually think the next big market correction will be (is) radiology reimbursement.

People should forget about pathology and go back to school to be an actuary. They are going to be a VITAL part of the health care "teams" of the future. Corners will need to be cut in areas like pathology and gas once payments are bundled. Hospitals will be overpaying for the first line specialists who will keep their supply and demand in check.
Oh and you will actually be recruited for jobs after actuary training, unlike pathology where you have to brown nose and network like crazy to find all those non-posted jobs.![]()
Not even I, who have a degree in it.
Besides, I wouldn't be surprised if computer algorithms will soon be able to comb though massive amounts of data so efficiently, actuaries will become obsolete as well. As well as researchers performing correlation studies...
It all comes down to math.
The surgical services are doing just fine with CRNAs at present. From a corporate perspective, one or two dead patients and the resulting malpractice payouts might still make the use of unqualified practitioners profitable if the volume is high enough.
Same with pathology. Since errors aren't particularly immediate in pathology, corporate interests are probably just fine with a few missed diagnoses by some incompetents because by the time the lawsuits come around, the interest and profit gained in the savings from paying the pathologists less may very well likely cover the malpractice payouts and then some.
I was also under the impression that malpractice falls under the domain of the practitioner moreso than the institution. If a stupid pathologist employee screws up at Quest, does Quest hold any liability?
Ignore the fools who tell you false positives are where most of the hits will come. Its all about FNs which is why most group QC operations are a joke. Unless they plan on double reading negatives as well as new positives, they are not catching the most dangerous sleepers.